Loading ARX…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("ARX","financials")Full statements spill as a table. For one cell: =jivedata("ARX","Revenue") or =jivedata("ARX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
ARX • CIK 0001997350
| (in thousands, except per share data) | FY 2025 | TTM |
|---|---|---|
| Premiums Earned, Net | $298,100 | $423,400 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-1,321,900 | $-1,270,300 |
| Net Investment Income | $48,700 | $43,000 |
| Income Tax Expense (Benefit) | $23,300 | $19,900 |
| Realized Investment Gains (Losses) | $7,900 | $31,300 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-1,345,200 | $-1,290,200 |
| Unrealized Gain (Loss) on Investments | $39,400 | $65,200 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $8,900 | $5,700 |
| Revenues | $912,900 | $1,146,000 |
| Temporary Equity, Dividends, Adjustment | $70,900 | $70,900 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $-1,425,000 | $-1,366,800 |
| Policyholder Benefits and Claims Incurred, Net | $204,000 | $261,000 |
| Deferred Policy Acquisition Costs, Amortization Expense | $80,300 | $113,400 |
| General and Administrative Expense | $400,400 | $494,700 |
| Interest Expense, Debt | $10,900 | $10,700 |
| Depreciation, Depletion and Amortization, Nonproduction | $35,200 | $39,900 |
| Foreign Currency Transaction Gain (Loss), before Tax | $-20,200 | $1,300 |
| Other Nonoperating Expense | $104,100 | $118,200 |
| Benefits, Losses and Expenses | $2,234,800 | $2,416,300 |
| Weighted Average Number of Shares Outstanding, Basic | 190,260,158 | 244,263,463 |
| Share-based Payment Arrangement, Expense | $53,600 | $105,500 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,273,669 | 29,350,853 |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 0 | -38,820,833 |
| (in thousands, except per share data) | FY 2025 | TTM |
|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,799,300 | $1,656,300 |
| Premiums Receivable, Net | $1,077,900 | $1,156,900 |
| Prepaid Reinsurance Premiums | $1,812,400 | $1,775,600 |
| Reinsurance Recoverable for Unpaid Claims and Claims Adjustments | $1,682,300 | $2,092,900 |
| Deferred Policy Acquisition Cost | $76,900 | $105,400 |
| Intangible Assets, Net (Including Goodwill) | $115,100 | $111,900 |
| Capitalized Computer Software, Net | $100,500 | $102,500 |
| Prepaid Expense and Other Assets | $198,100 | $234,200 |
| Assets | $8,263,100 | $8,943,300 |
| Liability for Claims and Claims Adjustment Expense | $2,005,400 | $2,273,700 |
| Unearned Premiums | $2,163,000 | $2,177,200 |
| Ceded Premiums Payable | $1,220,600 | $1,570,100 |
| Deferred Income | $232,500 | $225,100 |
| Funds Held under Reinsurance Agreements, Liability | $1,200,300 | $1,164,800 |
| Long-term Debt | $121,300 | $120,100 |
| Accounts Payable and Accrued Liabilities | $593,600 | $668,300 |
| Liabilities | $7,536,700 | $8,199,300 |
| Debt Securities, Available-for-sale | $712,000 | $662,200 |
| Equity Method Investments | $10,400 | $13,000 |
| Equity Securities without Readily Determinable Fair Value, Amount | $84,000 | $88,100 |
| Investments | $806,400 | $763,300 |
| Common Stock, Value, Issued | $0 | $0 |
| Additional Paid in Capital | $2,232,400 | $2,191,800 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2,200 | $-11,000 |
| Retained Earnings (Accumulated Deficit) | $-1,536,900 | $-1,463,400 |
| Stockholders' Equity Attributable to Parent | $697,700 | $717,400 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $28,700 | $26,600 |
| Debt Securities, Available-for-sale, Amortized Cost | $707,100 | $664,200 |
| Premium Receivable, Allowance for Credit Loss | $4,600 | $5,100 |
| Temporary Equity, Shares Issued | 5,556,546 | 5,556,546 |
| Preferred Stock, Shares Issued | 0 | 0 |
| Common Stock, Shares, Issued | 166,185,094 | 166,185,094 |
| Other Receivables | $84,500 | $84,500 |
| (in thousands, except per share data) | FY 2025 | TTM |
|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-1,345,200 | $-1,290,200 |
| Net Cash Provided by (Used in) Operating Activities | $445,100 | $45,800 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $477,300 | $220,500 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $49,000 | $-22,700 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,799,300 | $2,045,100 |
| Payments for (Proceeds from) Short-term Investments | $-28,500 | $4,900 |
| Payments to Acquire Businesses, Net of Cash Acquired | $9,900 | $17,900 |
| Payments to Develop Software | $41,400 | $44,000 |
| Payments for (Proceeds from) Other Investing Activities | $500 | $800 |
| Net Cash Provided by (Used in) Investing Activities | $-173,600 | $67,300 |
| Proceeds from Issuance of Common Stock | $392,000 | $392,000 |
| Payments for Repurchase of Preferred Stock and Preference Stock | $175,300 | $175,300 |
| Proceeds from Issuance of Convertible Preferred Stock | $0 | $0 |
| Proceeds from Lines of Credit | $5,000 | $0 |
| Repayments of Other Debt | $800 | $2,400 |
| Payments to Noncontrolling Interests | $2,100 | $9,600 |
| Payments of Ordinary Dividends, Noncontrolling Interest | $8,000 | $5,600 |
| Net Cash Provided by (Used in) Financing Activities | $205,800 | $107,400 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $10,000 | $9,400 |
| Income Taxes Paid, Net | $59,100 | $65,400 |
| Cash and Cash Equivalents, at Carrying Value | $1,716,200 | $1,930,300 |
| Restricted Cash and Cash Equivalents | $83,100 | $114,800 |
| Realized Investment Gains (Losses) | $7,900 | $31,300 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $306,100 | $453,000 |
| Unrealized Gain (Loss) on Investments | $39,400 | $65,200 |
| Proceeds from Sale of Equity Method Investments | $1,100 | $1,100 |
| Income (Loss) from Equity Method Investments | $1,800 | $2,500 |
| Proceeds from Sale of Other Investments | $3,600 | $54,500 |
| Share-based Payment Arrangement, Noncash Expense | $43,100 | $89,400 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $49,800 | $49,600 |
| Depreciation, Depletion and Amortization, Nonproduction | $35,200 | $39,900 |
| Deferred Income Tax Expense (Benefit) | $-32,000 | $-19,600 |
| Foreign Currency Transaction Gain (Loss), before Tax | $-20,200 | $1,300 |
| Accretion (Amortization) of Discounts and Premiums, Investments | $7,600 | $7,500 |
| Other Noncash Income (Expense) | $-3,000 | $-3,000 |
| Payments to Acquire Debt Securities, Available-for-sale | $509,300 | $420,700 |
| Payments to Acquire Equity Method Investments | $1,600 | $2,600 |
| Increase (Decrease) in Premiums Receivable | $258,600 | $230,900 |
| Increase (Decrease) in Prepaid Reinsurance Premiums | $225,900 | $-130,500 |
| Increase (Decrease) in Reinsurance Recoverable | $589,300 | $316,900 |
| Increase (Decrease) in Deferred Policy Acquisition Costs | $15,700 | $53,500 |
| Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | $645,300 | $613,500 |
| Increase (Decrease) in Unearned Premiums | $287,300 | $38,900 |
| Increase (Decrease) in Reinsurance Payables | $87,100 | $189,100 |
| Increase (Decrease) in Deferred Revenue | $55,500 | $-17,800 |
| Increase (Decrease) in Funds Held under Reinsurance Agreements | $-451,000 | $176,400 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $-180,400 | $-214,400 |